Cobra Bio, South African AIDS Vaccine Initiative deal

CBF will use its ORT manufacturing technology to supply the initiative with DNA for Phase I/II trials of the institute's preclinical vaccine for HIV-1 Clade C virus. That form of the virus is the most...